Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1984 Oct;18(4):641–644. doi: 10.1111/j.1365-2125.1984.tb02520.x

Cardiovascular and biochemical responses to nebulised salbutamol in normal subjects.

S R Smith, C Ryder, M J Kendall, R Holder
PMCID: PMC1463610  PMID: 6487508

Abstract

When conventional therapeutic doses of nebulised salbutamol were given to normal volunteers, there was a significant rise in pulse rate, systolic blood pressure and plasma glucose and a significant fall in diastolic blood pressure and serum potassium in comparison with placebo. Such changes may be potentially hazardous in certain situations. Patients with airways obstruction due to chronic bronchitis who have coexistent ischaemic heart disease or diuretic induced hypokalaemia may be at particular risk from the unwanted cardiovascular and biochemical responses to nebulised salbutamol.

Full text

PDF
641

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bateman S. M., Pidgeon J., Spiro S. G., Johnson A. J. The metabolic effects of inhaled salbutamol. Br J Clin Pharmacol. 1978 Feb;5(2):127–129. doi: 10.1111/j.1365-2125.1978.tb01612.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Holland O. B., Nixon J. V., Kuhnert L. Diuretic-induced ventricular ectopic activity. Am J Med. 1981 Apr;70(4):762–768. doi: 10.1016/0002-9343(81)90530-1. [DOI] [PubMed] [Google Scholar]
  3. Kendall M. J., Dean S., Bradley D., Gibson R., Worthington D. J. Cardiovascular and metabolic effects of terbutaline. J Clin Hosp Pharm. 1982 Mar;7(1):31–36. doi: 10.1111/j.1365-2710.1982.tb00905.x. [DOI] [PubMed] [Google Scholar]
  4. Neville A., Palmer J. B., Gaddie J., May C. S., Palmer K. N., Murchison L. E. Metabolic effects of salbutamol: comparison of aerosol and intravenous administration. Br Med J. 1977 Feb 12;1(6058):413–414. doi: 10.1136/bmj.1.6058.413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Neville E., Corris P. A., Vivian J., Nariman S., Gibson G. J. Nebulised salbutamol and angina. Br Med J (Clin Res Ed) 1982 Sep 18;285(6344):796–797. doi: 10.1136/bmj.285.6344.796. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Simonsson B. G., Svedenblad H., Axelsson I., Andersson A. L. Systemic effects of inhalation of terbutaline with IPPB in normal subjects. Scand J Respir Dis. 1974;55(1):19–24. [PubMed] [Google Scholar]
  7. Walters E. H., Cockroft A., Griffiths T., Rocchiccioli K., Davies B. H. Optimal dose of salbutamol respiratory solution: comparison of three doses with plasma levels. Thorax. 1981 Aug;36(8):625–628. doi: 10.1136/thx.36.8.625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Williams S. J., Winner S. J., Clark T. J. Comparison of inhaled and intravenous terbutaline in acute severe asthma. Thorax. 1981 Aug;36(8):629–631. doi: 10.1136/thx.36.8.629. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES